Dianthus Therapeutics, Inc. · NASDAQ:DNTH

Octagon Capital Advisors LP reported a 6.10% stake in Dianthus Therapeutics, Inc. (Schedule 13G/A)

Event Sep 30, 2025 · Filed Nov 14, 2025

Octagon Capital Advisors LP reported a 6.10% stake in Dianthus Therapeutics, Inc., 2,416,667 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).

Stake
6.10%
Shares
2,416,667
Intent
Passive
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
Octagon Capital Advisors LP6.10%2,416,667
Octagon Investments Master Fund LP5.30%2,125,000
Octagon Private Opportunities Fund II LP0.70%291,667
Ting Jia6.10%2,416,667

Source

View original at SEC

Related